The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, open label, first-in-human study of an oncolytic viral vector expressing an agonistic anti-CD40 antibody (NG-350A) in patients with epithelial tumors (FORTITUDE).
 
Aung Naing
Consulting or Advisory Role - CytomX Therapeutics; Novartis
Research Funding - Amplimmune; ARMO BioSciences; Atterocor; Bristol-Myers Squibb; Calithera Biosciences; CytomX Therapeutics; EMD Serono; Healios; Immune Cell Therapy (I); Incyte; Karyopharm Therapeutics; Kyocera; Lilly; MedImmune; Merck; NCI; Neon Therapeutics; Novartis; Pfizer; Regeneron; TopAlliance BioSciences Inc
Travel, Accommodations, Expenses - ARMO BioSciences
 
Ecaterina Elena Ileana Dumbrava
No Relationships to Disclose
 
Ravi Murthy
Employment - Daedalus Interventional, LLC
Stock and Other Ownership Interests - Daedalus Interventional, LLC
Patents, Royalties, Other Intellectual Property - Daedalus Interventional, LLC
 
Funda Meric-Bernstam
Honoraria - Dialectica; Sumitomo Group
Consulting or Advisory Role - Aduro Biotech; Clearlight Diagnostics; DarwinHealth; Debiopharm Group; Genentech; Inflection Biosciences; Mersana; Origimed; Pieris Pharmaceuticals; Samsung Bioepis; Spectrum Pharmaceuticals; Xencor
Research Funding - Abbvie; Aileron Therapeutics; AstraZeneca; Bayer; Boehringer Ingelheim (I); Calithera Biosciences; Curis; CytomX Therapeutics; Daiichi Sankyo; Debiopharm Group; eFFECTOR Therapeutics; Genentech; GlaxoSmithKline; Guardant Health (Inst); Jounce Therapeutics; Novartis; Pfizer; PUMA Biotechnology; Taiho Pharmaceutical; Zymeworks
 
Andrew Fox
Employment - PsiOxus Therapeutics
Stock and Other Ownership Interests - AstraZeneca; PsiOxus Therapeutics
Consulting or Advisory Role - StepStone Pharma; Vifor Pharma
 
David Krige
Employment - Immunocore; PsiOxus Therapeutics
Stock and Other Ownership Interests - Immunocore
 
Jo Carter
Employment - PsiOxus Therapeutics
 
Brian Champion
Employment - PsiOxus Therapeutics
Leadership - PsiOxus Therapeutics
Stock and Other Ownership Interests - PsiOxus Therapeutics
 
Paul Cockle
Employment - PsiOxus Therapeutics
Stock and Other Ownership Interests - Pfizer
Patents, Royalties, Other Intellectual Property - Pfizer
 
Barbara Koetz
Employment - Teva
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; PsiOxus Therapeutics; Roche
 
Hilary McElwaine-Johnn
Employment - PsiOxus Therapeutics
Leadership - PsiOxus Therapeutics
Stock and Other Ownership Interests - PsiOxus Therapeutics